These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4231173)

  • 1. [Attempts at the isolation and characterization of immunogenically active fractions from Mycobacterium tuberculosis and Myocbacterium bovis (BCG). I. Preparation and purification of the preparations].
    Klose F; Schallehn G
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Aug; 131(2):105-19. PubMed ID: 4231173
    [No Abstract]   [Full Text] [Related]  

  • 2. [Attempts at isolation and characterization of immunogenically active fractions from Mycobacterium tuberculosis and Mycobacterium bovis (BCG). II. Physical-chemical characterization of the fractions].
    Klose F; Schallehn G
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Aug; 131(2):121-33. PubMed ID: 4231174
    [No Abstract]   [Full Text] [Related]  

  • 3. [Attempts at isolation and characterization of immunogenically active fractions of Mycobacterium tuberculosis and Mycobacterium bovis (BCG). 3. Immunochemical properties of the fractions].
    Klose F; Schallehn G
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Sep; 131(3):201-18. PubMed ID: 4231179
    [No Abstract]   [Full Text] [Related]  

  • 4. [Attempts at isolation and characterization of immunogenically active fractions from Mycobacterium tuberculosis and Mycobacterium bovis (BCG). IV. Immunobiologic properties of the fractions].
    Klose F; Schallehn G
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Sep; 131(3):219-35. PubMed ID: 4231180
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemical and immunologic studies of 2 antigen active preparations with polysaccharide characteristics obtained from Mycobacterium tuberculosis and Mycobacterium bovis (BCG)].
    Klose F; Weyhers M
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Jun; 133(1):7-10. PubMed ID: 4232429
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the specificity and antigenic composition of fractions from Mycobacterium tuberculosis, bovine type and Mycobacterium fortuitum. 3. Hemagglutination, hemolysis and complement fixation reactions].
    Micke H
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Aug; 131(2):134-69. PubMed ID: 4231175
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the antigenic structure of mycobacteria. I. Comparison of the antigenic structure of pathogenic and saprophytic mycobacteria.
    Tuboly S
    Acta Microbiol Acad Sci Hung; 1965; 12(3):233-40. PubMed ID: 4955241
    [No Abstract]   [Full Text] [Related]  

  • 9. The isolation from romanian BCG substrain of non cross reacting antigens to Mycobacterium tuberculosis H37Rv strain.
    Niculescu D; Stavri D; Stavri H; Claiciu I; Bărbulescu R
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):213-9. PubMed ID: 6424629
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycobacterium tuberculosis tuberculin devoid of BCG common antigens.
    Stavri D; Stavri H; Claiciu I; Niculescu D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):399-401. PubMed ID: 6805158
    [No Abstract]   [Full Text] [Related]  

  • 11. Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection.
    Palendira U; Spratt JM; Britton WJ; Triccas JA
    Vaccine; 2005 Feb; 23(14):1680-5. PubMed ID: 15705472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of rapid serodiagnosis in pulmonary tuberculosis by ELISA with glycolipidic antigens extracted from Mycobacterium tuberculosis and with whole BCG suspension.
    Niculescu D; Stavri H; Teodor I; Popa M; Stavri D; Ciomu E; Homoş M; Popescu L
    Roum Arch Microbiol Immunol; 1995; 54(4):277-84. PubMed ID: 8993121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagosomal membranes of Mycobacterium bovis BCG-immune alveolar macrophages are resistant to disruption by Mycobacterium tuberculosis H37Rv.
    Leake ES; Myrvik QN; Wright MJ
    Infect Immun; 1984 Aug; 45(2):443-6. PubMed ID: 6430807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis.
    Feng CG; Palendira U; Demangel C; Spratt JM; Malin AS; Britton WJ
    Infect Immun; 2001 Jun; 69(6):4174-6. PubMed ID: 11349095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.
    Andersen CS; Dietrich J; Agger EM; Lycke NY; Lövgren K; Andersen P
    Infect Immun; 2007 Jan; 75(1):408-16. PubMed ID: 17074845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae.
    Kolk AH; Ho ML; Klatser PR; Eggelte TA; Kuijper S; de Jonge S; van Leeuwen J
    Clin Exp Immunol; 1984 Dec; 58(3):511-21. PubMed ID: 6439449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on mycobacterial sensitizing fractions. IV. Fractionation of components of unheated M. tuberculosis and BCG culture filtrates by successive precipitation with CH3COOH, HClO4 and CCl3COOH.
    Rzucidlo L; Piwowarczyk M; Ziolecka I
    Acta Microbiol Pol A; 1969; 1(1):41-8. PubMed ID: 4312909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.